PASITHEA THERAPEUTICS CORP. Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share
PASITHEA THERAPEUTICS CORP. (KTTA) reported Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share of -$0.37 per share for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-24.
Financial Statements › Income Statement › Net Income
us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare · last filed 2025-03-24
- PASITHEA THERAPEUTICS CORP. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2023-06-30 was -$0.13.
- PASITHEA THERAPEUTICS CORP. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2023-03-31 was -$0.20.
- PASITHEA THERAPEUTICS CORP. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for fiscal 2023 was -$0.37.
- PASITHEA THERAPEUTICS CORP. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for fiscal 2022 was -$1.74.
| Period end | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 3 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 6 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 9 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 12 month |
|---|---|---|---|---|
| 2023-12-31 | -$0.37 10-K · filed 2025-03-24 | |||
| 2023-09-30 | -$0.34 10-Q · filed 2024-11-13 | |||
| 2023-06-30 | -$0.13 10-Q · filed 2024-08-13 | -$0.33 10-Q · filed 2024-08-13 | ||
| 2023-03-31 | -$0.20 10-Q · filed 2024-05-14 | |||
| 2022-12-31 | -$1.74 10-K · filed 2024-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |